Fundraising Fox

Li-Yao Huang

Founder

Founder at FinalDose

Oxford, England, United Kingdom

FoundedFinalDose Β· YC

About

Li-Yao Huang holds a DPhil in Biochemistry from Oxford and conducted postdoctoral research at the MRC Weatherall Institute of Molecular Medicine, where he led CRISPR screening projects focused on cancer drug targets. He now leads FinalDose, a YC-backed company working on BRCA1-deficient cancers and PARP inhibitor resistance mechanisms.

Founder at FinalDoseYC X26

Intro paths

YC

Li-Yao went through Y Combinator (Spring 2026) β€” any YC alum in your network can reach them through the YC community.

GP

Their group partner at YC was Garry Tan, President & CEO of Y Combinator β€” the partner who ran FinalDose's batch and knows the company first-hand. YC profile β†—

β†’

In turn, Li-Yao can intro founders to FinalDose's investors below.

Co-founders at FinalDose

SLSteven Lin
Steven LinFounder
JLJeff Liu
Jeff LiuFounder

Experience

  1. FinalDoseChief Scientific Officercurrent2026 β€” presentOxford, England, United Kingdom
  2. MRC Weatherall Institute of Molecular MedicinePostdoctoral Researcher2020 β€” 2025Oxford, England, United Kingdom
  3. The Department of Biochemistry, University of OxfordPostdoctoral Researcher2020Oxford, England, United Kingdom

Frequently asked questions

Who is Li-Yao Huang?
Li-Yao Huang holds a DPhil in Biochemistry from Oxford and conducted postdoctoral research at the MRC Weatherall Institute of Molecular Medicine, where he led CRISPR screening projects focused on cancer drug targets. He now leads FinalDose, a YC-backed company working on BRCA1-deficient cancers and PARP inhibitor resistance mechanisms.
Where does Li-Yao Huang work?
Li-Yao Huang is Founder of FinalDose.
What companies did Li-Yao Huang found?
Li-Yao Huang founded FinalDose.
Where did Li-Yao Huang go to school?
Li-Yao Huang studied at University of Oxford (DPhil in Biochemistry); National Cheng Kung University (MS, Life Sicence).

Founder mafias

Same school

Shared employers

Also worked at MRC Weatherall Institute of Molecular Medicine1